Matches in Wikidata for { <http://www.wikidata.org/entity/Q38002431> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q38002431 description "article científic" @default.
- Q38002431 description "article scientifique" @default.
- Q38002431 description "articol științific" @default.
- Q38002431 description "articolo scientifico" @default.
- Q38002431 description "artigo científico" @default.
- Q38002431 description "artigo científico" @default.
- Q38002431 description "artigo científico" @default.
- Q38002431 description "artikel ilmiah" @default.
- Q38002431 description "artikull shkencor" @default.
- Q38002431 description "artículo científico" @default.
- Q38002431 description "artículu científicu espublizáu en 2012" @default.
- Q38002431 description "bilimsel makale" @default.
- Q38002431 description "scienca artikolo" @default.
- Q38002431 description "scientific article published on 14 February 2012" @default.
- Q38002431 description "scientific article published on 14 February 2012" @default.
- Q38002431 description "scientific article published on 14 February 2012" @default.
- Q38002431 description "vedecký článok" @default.
- Q38002431 description "vetenskaplig artikel" @default.
- Q38002431 description "videnskabelig artikel" @default.
- Q38002431 description "vitenskapelig artikkel" @default.
- Q38002431 description "vitskapeleg artikkel" @default.
- Q38002431 description "vědecký článek" @default.
- Q38002431 description "wetenschappelijk artikel" @default.
- Q38002431 description "wissenschaftlicher Artikel" @default.
- Q38002431 description "наукова стаття, опублікована в лютому 2012" @default.
- Q38002431 description "научная статья" @default.
- Q38002431 description "научни чланак" @default.
- Q38002431 description "מאמר מדעי" @default.
- Q38002431 description "مقالة علمية نشرت في 14 فبراير 2012" @default.
- Q38002431 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38002431 name "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 name "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 name "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 type Item @default.
- Q38002431 label "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 label "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 label "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 prefLabel "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 prefLabel "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 prefLabel "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 P1433 Q38002431-8680ED69-69F8-4CDF-8ED7-9D3DF183E517 @default.
- Q38002431 P1476 Q38002431-0C8A43CF-B6F1-455D-8245-A87F8447B568 @default.
- Q38002431 P2093 Q38002431-2D64936A-BEEF-4777-9DDF-D0D5980536C5 @default.
- Q38002431 P2093 Q38002431-2FB96F4F-719C-4B27-A7E8-5CF77A68CDC7 @default.
- Q38002431 P2093 Q38002431-C2C2D88B-706A-43A1-8138-599082000789 @default.
- Q38002431 P304 Q38002431-31791B06-2FED-4B01-B26C-671EC2639F83 @default.
- Q38002431 P31 Q38002431-0C6C166F-0EF5-49E2-8767-118E0B27784D @default.
- Q38002431 P356 Q38002431-1D1E5D9A-9F92-414C-A585-E48BB971D70B @default.
- Q38002431 P407 Q38002431-09B3D6D7-2230-460E-BD04-ECC1BE41E9A1 @default.
- Q38002431 P433 Q38002431-3D9D2349-611C-4A46-A941-9E8419042E72 @default.
- Q38002431 P478 Q38002431-417F9D11-6D59-4075-9DF2-8117239988C2 @default.
- Q38002431 P50 Q38002431-FA38A989-F134-4391-937E-ABE29655A464 @default.
- Q38002431 P577 Q38002431-56DC7B9B-CDA9-4D10-AD4A-ACC91D02ED26 @default.
- Q38002431 P698 Q38002431-CDFD03AE-0FA4-4615-8399-E794C2F82520 @default.
- Q38002431 P921 Q38002431-1E756C82-9B28-4F41-9332-1A47FE27A535 @default.
- Q38002431 P356 J.GTC.2012.01.012 @default.
- Q38002431 P698 22500526 @default.
- Q38002431 P1433 Q15756082 @default.
- Q38002431 P1476 "Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease" @default.
- Q38002431 P2093 "BRIDGe group" @default.
- Q38002431 P2093 "Corey A Siegel" @default.
- Q38002431 P2093 "Shane M Devlin" @default.
- Q38002431 P304 "411-428" @default.
- Q38002431 P31 Q13442814 @default.
- Q38002431 P356 "10.1016/J.GTC.2012.01.012" @default.
- Q38002431 P407 Q1860 @default.
- Q38002431 P433 "2" @default.
- Q38002431 P478 "41" @default.
- Q38002431 P50 Q67425996 @default.
- Q38002431 P577 "2012-02-14T00:00:00Z" @default.
- Q38002431 P698 "22500526" @default.
- Q38002431 P921 Q917447 @default.